CDMOMeet us at Tides Europe 2026, Stand No. 805, Nov 3-5, RAI Amsterdam, Netherlands Schedule a Meeting
Expert insights on API manufacturing, CDMO trends, peptide development, and pharmaceutical industry news from Neuland Labs.
CDMO
CDMOBiotech companies are increasingly outsourcing drug development and manufacturing to CDMOs rather than building in-house facilities, driven by molecule complexity, capital efficiency, and speed-to-clinic pressures in the pharmaceutical industry.
CDMOContract drug manufacturing involves outsourcing R&D and production to specialized partners (CDMOs) who guide molecules through interconnected stages, from route scouting and process development to kilo lab production.
CDMOA comprehensive guide explaining what CDMOs are, how they differ from CMOs and CROs, and why pharmaceutical companies increasingly outsource drug development and manufacturing to specialized partners.
CDMONeuland Labs outlines how Contract Development and Manufacturing Organizations can implement structured Enterprise Risk Management frameworks to identify, assess, and mitigate operational, regulatory, and strategic risks across their manufacturing and supply chain operations.
CDMOA guide to CDMO API manufacturing for complex molecules, covering process development, scale-up, GMP compliance, and how to select the right contract partner.
CDMO
CDMO